MedTrace Logo

Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients

NCT03651492 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-08-29

No results posted yet for this study

Summary

Nocturnal hypertension (i.e. blood pressure values \>120/70 or 10% higher than diurnal values, as measured by ambulatory blood pressure monitoring, ABPM) is particularly frequent in renal transplant recipients (RTR), despite the use of antihypertensive drugs. Since RTR are also affected by several sleep disorders (like insomnia, restless legs syndrome, sleep apnoea) that frankly impair their quality of sleep (SQ), the aim of the present study is to ascertain whether a relationship exists between nocturnal hypertension and SQ. In fact, both nocturnal hypertension and sleep disorders may favour the onset or the progression of cardiovascular diseases, the first cause of death in RTR.

Conditions

  • Hypertension; Nephropathy
  • Renal Transplant
  • Sleep Disorder

Interventions

BEHAVIORAL

questionnaire administration

All the patients will be administered the Pittsburgh Questionnaire after completion of ABPM.

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-06-01
Completion
2020-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651492 on ClinicalTrials.gov